نتایج جستجو برای: torsades de pointes

تعداد نتایج: 1531888  

2004
J. Dauzat N. Lamanda Y. Nouvellon

4th International Workshop on Functional-Structural Plant Models, 7-11 june 2004 –Montpellier, France Edited by C. Godin et al., pp. 201-205 Multiscale modelling of gap fractions within stands J. Dauzat, N. Lamanda, Y. Nouvellon 1 UMR AMAP, TA 40 / PS2, 34398 Montpellier cedex 05, France 2 Cirad cp-cocotier, TA 80/01, 34398 Montpellier 5, France 3 Cirad forêt-plantations, BP 1264 Pointe-Noire R...

Journal: :Circulation 2008
Dan M Roden

Clinicians are well aware that responses to QT-prolonging drugs vary among individuals.1 A drug dose (and concentration) that produces minimal QT prolongation in one patient may, in an apparently indistinguishable subject, produce marked QT prolongation and torsade de pointes. This variability in response to an exogenous stressor is paralleled by variability in the extent to which a given mutat...

Journal: :Circulation. Cardiovascular genetics 2012
Stefan Kääb Dana C Crawford Moritz F Sinner Elijah R Behr Prince J Kannankeril Arthur A M Wilde Connie R Bezzina Eric Schulze-Bahr Pascale Guicheney Nanette H Bishopric Robert J Myerburg Jean-Jacques Schott Arne Pfeufer Britt-Maria Beckmann Eimo Martens Taifang Zhang Birgit Stallmeyer Sven Zumhagen Isabelle Denjoy Abdennasser Bardai Isabelle C Van Gelder Yalda Jamshidi Chrysoula Dalageorgou Vanessa Marshall Steve Jeffery Saad Shakir A John Camm Gerhard Steinbeck Siegfried Perz Peter Lichtner Thomas Meitinger Annette Peters H-Erich Wichmann Christiana Ingram Yuki Bradford Shannon Carter Kris Norris Marylyn D Ritchie Alfred L George Dan M Roden

BACKGROUND Drug-induced long-QT syndrome (diLQTS) is an adverse drug effect that has an important impact on drug use, development, and regulation. We tested the hypothesis that common variants in key genes controlling cardiac electric properties modify the risk of diLQTS. METHODS AND RESULTS In a case-control setting, we included 176 patients of European descent from North America and Europe ...

2014
Shimpei Nakatani Masayuki Taniike Nobuhiko Makino Yasuyuki Egami Ryu Shutta Jun Tanouchi Masami Nishino

An 84-year-old male received oral pilsicainide, a pure sodium channel blocker with slow recovery kinetics, to convert his paroxysmal atrial fibrillation to a sinus rhythm; the patient developed sudden cardiac death two days later. The Holter electrocardiogram, which was worn by chance, revealed torsade de pointes with gradually prolonged QT intervals. This drug is rapidly absorbed from the gast...

Journal: :Anesthesiology 2005
Susan J Kies Christina M Pabelick Heather A Hurley Roger D White Michael J Ackerman

Long QT syndrome is a malfunction of cardiac ion channels resulting in impaired ventricular repolarization that can lead to a characteristic polymorphic ventricular tachycardia known as torsades de pointes. Stressors, by increasing sympathetic tone, and drugs can provoke torsade de pointes, leading to syncope, seizures, or sudden cardiac death in these patients. Beta blockade, implantation of c...

Journal: :Circulation journal : official journal of the Japanese Circulation Society 2009
Masaru Inoue Honin Kanaya Takao Matsubara Yoshihide Uno Toshihiko Yasuda Kenji Miwa

An 82-year-old woman was admitted to the hospital due to repeated episodes of syncope with incontinence. Electrocardiography showed torsades de pointes, complete atrioventricular (AV) block, T-wave inversions and a prolonged QTc interval. Urgent coronary angiography showed no significant coronary stenosis and left ventriculography demonstrated typical abnormal wall motion of takotusbo cardiomyo...

2012
Eleftherios M. Kallergis Christos A. Goudis Emmanuel N. Simantirakis George E. Kochiadakis Panos E. Vardas

Long QT syndrome is characterized by prolongation of the corrected QT (QTc) interval on the surface electrocardiogram and is associated with precipitation of torsade de pointes (TdP), a polymorphic ventricular tachycardia that may cause sudden death. Acquired long QT syndrome describes pathologic excessive prolongation of the QT interval, upon exposure to an environmental stressor, with reversi...

Journal: :Journal of the American College of Cardiology 2020

Journal: :British journal of pharmacology 2012
D L Misner C Frantz L Guo M R Gralinski P B Senese J Ly M Albassam K L Kolaja

BACKGROUND AND PURPOSE Drug candidates must be thoroughly investigated for their potential cardiac side effects. During the course of routine toxicological assessment, the compound RO5657, a CCR5 antagonist, was discovered to have the rare liability of inducing torsades de pointes (polymorphic ventricular arrhythmia) in normal, healthy animals. Studies were conducted to determine the molecular ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید